| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| b' Kosta J Popovi\\xc4\\x87, Du\\xc5\\xa1ica J Popovi\\xc4\\x87, Dejan Miljkovi\\xc4\\x87, Du\\xc5\\xa1an Lalo\\xc5\\xa1evi\\xc4\\x87, Ivan \\xc4\\x8capo, Jovan K Popovi\\xc4\\x8. Physicochemical and pathohistological changes in experimental fibrosarcoma tumors of hamsters treated with metformin and itraconazole. Oncology letters. vol 18. issue 2. 2020-09-30. PMID:31423237.' |
the tumor samples were pathohistologically and immunohistochemically assessed for proliferation marker protein ki-67, hematopoietic progenitor cell antigen cd34, cytochrome |
2020-09-30 |
2023-08-13 |
Not clear |
| Rica Tanaka, Yuri Umeyama, Hiroko Hagiwara, Rie Ito-Hirano, Satoshi Fujimura, Hiroshi Mizuno, Rei Ogaw. Keloid patients have higher peripheral blood endothelial progenitor cell counts and CD34 International journal of dermatology. vol 58. issue 12. 2020-05-05. PMID:31290139. |
keloid patients have higher peripheral blood endothelial progenitor cell counts and cd34 one suggested reason for aberrant wound healing in keloid scars is chronic inflammation of the dermis. |
2020-05-05 |
2023-08-13 |
Not clear |
| Diana Vanegas, Cristian-Camilo Galindo, Iván-Aurelio Páez-Gutiérrez, Lorena-Xiomara González-Acero, Pavel-Tiberio Medina-Valderrama, Juan-Camilo Lozano, Bernardo Camacho-Rodríguez, Ana-María Perdomo-Arciniega. Human Leukocyte Antigen and Red Blood Cells Impact Umbilical Cord Blood CD34 International journal of molecular sciences. vol 20. issue 19. 2020-02-10. PMID:31575081. |
human leukocyte antigen and red blood cells impact umbilical cord blood cd34 hematopoietic progenitor cell (hpc) transplantation is a treatment option for malignant and nonmalignant diseases. |
2020-02-10 |
2023-08-13 |
human |
| S.-M. Hsu, J. Waldron, S.-S. Xie, P.-L. Hs. Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. ii. from cytokines to cell lineage. Journal of biomedical science. vol 3. issue 1. 2019-11-20. PMID:11725077. |
the progenitor cell hypothesis may explain (1) the variable expression of cd117, cd43, and cd34 as well as the absence of cd27, cd45 and cd45ra in h-rs cells; (2) the inconsistent and irregular patterns of phenotype and genotype and the various, often very limited, degrees of differentiation among these two types of lymphoma cells; (3) the existence of secondary hd or alcl associated with rare types of lymphomas or leukemias, or vice versa; (4) the absence of recombinase and of the b-specific transcription factors bsap; and (5) the frequent expression of il-7 and il-9 in h-rs cells. |
2019-11-20 |
2023-08-12 |
human |
| Eytan Abraham, Or Gadish, Joseph W Franses, Vipul C Chitalia, Natalie Artzi, Elazer R Edelma. Matrix-Embedded Endothelial Cells Attain a Progenitor-Like Phenotype. Advanced biosystems. vol 1. issue 9. 2019-11-20. PMID:29862313. |
this manifests in elevation of cd34 expression-a progenitor cell marker-and protein secretion and gene expression pro-files that are similar to epcs. |
2019-11-20 |
2023-08-13 |
Not clear |
| Manal Abdel-Salam, Ragaa Abd Elsalam, Nadia Youssef, Fadila Mamdouh, Taghreed Abdel-Sala. Evaluation of endothelial progenitor cell (CD34) as a marker of cardiovascular risk in children on regular hemodialysis. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. vol 29. issue 4. 2019-10-21. PMID:30152413. |
evaluation of endothelial progenitor cell (cd34) as a marker of cardiovascular risk in children on regular hemodialysis. |
2019-10-21 |
2023-08-13 |
Not clear |
| Anna-Maria Husa, Maria Regina Strobl, Agata Strajeriu, Matthias Wieser, Sabine Strehl, Klaus Fortschegge. Generation of CD34 Fluorescent Reporter Human Induced Pluripotent Stem Cells for Monitoring Hematopoietic Differentiation. Stem cells and development. vol 27. issue 19. 2019-09-19. PMID:30009677. |
to facilitate the monitoring of hematopoietic differentiation of hipscs, we established fluorescent reporter cells for the stem and progenitor cell marker cd34. |
2019-09-19 |
2023-08-13 |
human |
| Farid Boulad, Tsiporah Shore, Koen van Besien, Caterina Minniti, Mihaela Barbu-Stevanovic, Sylvie Wiener Fedus, Fabiana Perna, June Greenberg, Danielle Guarneri, Vijay Nandi, Audrey Mauguen, Karina Yazdanbakhsh, Michel Sadelain, Patricia A Sh. Safety and efficacy of plerixafor dose escalation for the mobilization of CD34 Haematologica. vol 103. issue 5. 2019-07-08. PMID:29419425. |
we therefore performed a phase i dose-escalation study of the hematopoietic progenitor cell mobilizing agent plerixafor to evaluate the efficacy and safety of standard dosing on peripheral blood cd34 |
2019-07-08 |
2023-08-13 |
Not clear |
| Irina Bure, Alexander Braun, Claudia Kayser, Helene Geddert, Inga-Marie Schaefer, Silke Cameron, Michael B Ghadimi, Philipp Ströbel, Martin Werner, Arndt Hartmann, Stefan Wiemann, Abbas Agaimy, Florian Haller, Evgeny A Moskale. The expression of hematopoietic progenitor cell antigen CD34 is regulated by DNA methylation in a site-dependent manner in gastrointestinal stromal tumours. International journal of cancer. vol 141. issue 11. 2017-10-20. PMID:28744850. |
the expression of hematopoietic progenitor cell antigen cd34 is regulated by dna methylation in a site-dependent manner in gastrointestinal stromal tumours. |
2017-10-20 |
2023-08-13 |
Not clear |
| Irina Bure, Alexander Braun, Claudia Kayser, Helene Geddert, Inga-Marie Schaefer, Silke Cameron, Michael B Ghadimi, Philipp Ströbel, Martin Werner, Arndt Hartmann, Stefan Wiemann, Abbas Agaimy, Florian Haller, Evgeny A Moskale. The expression of hematopoietic progenitor cell antigen CD34 is regulated by DNA methylation in a site-dependent manner in gastrointestinal stromal tumours. International journal of cancer. vol 141. issue 11. 2017-10-20. PMID:28744850. |
the anatomic site-dependent expression of hematopoietic progenitor cell antigen cd34 is a feature of gastrointestinal stromal tumours (gists). |
2017-10-20 |
2023-08-13 |
Not clear |
| Laura Cooling, Kelly Roxbury, Sandra Hoffmann, Joan DeBusscher, Usha Kota, Steven Goldstein, Robertson Davenpor. Use of allogeneic apheresis stem cell products as an interlaboratory proficiency challenge. Transfusion. vol 57. issue 6. 2017-09-19. PMID:28370131. |
we investigated the utility of allogeneic hematopoietic progenitor cell apheresis (hpc-a) products as an interlaboratory pt challenge for total nucleated cell count (tnc) and cd34 assessment. |
2017-09-19 |
2023-08-13 |
Not clear |
| Sisi Chen, Rui Gao, Michihiro Kobayashi, Hao Yu, Chonghua Yao, Reuben Kapur, Mervin C Yoder, Yan Li. Pharmacological inhibition of AKT activity in human CD34 Experimental hematology. vol 45. 2017-06-06. PMID:27645691. |
to determine the role of phosphoinositide 3-kinase (pi3k)/akt signaling in human hematopoietic stem and progenitor cell (hspc) maintenance, we examined the effect of genetic and pharmacological inhibition of akt on human umbilical cord blood (ucb) cd34 |
2017-06-06 |
2023-08-13 |
human |
| Katie Caviness, Farah Bughio, Lindsey B Crawford, Daniel N Streblow, Jay A Nelson, Patrizia Caposio, Felicia Goodru. Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency. mBio. vol 7. issue 2. 2017-01-10. PMID:26933055. |
in our current work, ul136 has emerged as a complex regulator of hcmv infection in multiple contexts of infection relevant to hcmv persistence: in an endothelial cell (ec) model of chronic infection, in a cd34(+) hematopoietic progenitor cell (hpc) model of latency, and in an in vivo nod-scid il2rγc (null) humanized (hunsg) mouse model for latency. |
2017-01-10 |
2023-08-13 |
mouse |
| Liang Guo, John Hamre, Myrtle Davis, Ralph E Parchmen. Human CD34(+) progenitor hematopoiesis in liquid culture for in vitro assessment of drug-induced myelotoxicity. Toxicology in vitro : an international journal published in association with BIBRA. vol 31. 2016-10-11. PMID:26616282. |
these results suggest that this human cd34(+) hematopoietic progenitor cell assay can be used as a direct replacement for the validated, low throughput cfu-gm assay, and could expand application of in vitro myelotoxicity testing. |
2016-10-11 |
2023-08-13 |
human |
| Xing-Bing Wang, Xin Chen, Kai-di Song, Jian Wang, Wen Yao, Hui-Lan Liu, Zi-Min Su. [Effects of HMGB1 on human cord blood CD34(+) hematopoietic stem cells proliferation and differentiation in vitro.]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. vol 31. issue 2. 2016-04-23. PMID:20302794. |
to study both the release of hmgb1 from irradiation-treated mesenchymal stem cells (mscs) and the effects of hmgb1 on human cord blood cd34(+) hematopoietic progenitor cell proliferation and differentiation. |
2016-04-23 |
2023-08-12 |
human |
| Mirella Meregalli, Andrea Farini, Marzia Belicchi, Yvan Torrent. CD133(+) Cells for the Treatment of Degenerative Diseases: Update and Perspectives. Advances in experimental medicine and biology. vol 777. 2016-04-23. PMID:23161086. |
the expression of human cd133 (ac133 antigen) was originally described in the hematopoietic cd34(+) stem cells, but now it becomes more and more evident that cd133 is a marker of stem and progenitor cell populations originating from various tissues and organs. |
2016-04-23 |
2023-08-12 |
human |
| Lachlan M Moldenhauer, Michaelia P Cockshell, Lachlan Frost, Kate A Parham, Denis Tvorogov, Lih Y Tan, Lisa M Ebert, Katie Tooley, Stephen Worthley, Angel F Lopez, Claudine S Bonde. Interleukin-3 greatly expands non-adherent endothelial forming cells with pro-angiogenic properties. Stem cell research. vol 14. issue 3. 2016-03-25. PMID:25900163. |
cell surface marker phenotyping confirmed expression of the hematopoietic progenitor cell markers cd133, cd117 and cd34, vascular cell markers vegfr2 and cd31, dim expression of cd45 and absence of myeloid markers cd14 and cd11b. |
2016-03-25 |
2023-08-13 |
mouse |
| Hakan Goker, Sezgin Etgul, Yahya Buyukasi. Optimizing mobilization strategies in difficult-to-mobilize patients: The role of plerixafor. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. vol 53. issue 1. 2016-03-21. PMID:26099666. |
several factors such as advanced age, previous chemotherapy, disease and marrow infiltration at the time of mobilization influence the efficacy of cd34(+) progenitor cell mobilization. |
2016-03-21 |
2023-08-13 |
Not clear |
| Jui-Ting Yu, Shao-Bin Cheng, Youngsen Yang, Kuang-Hsi Chang, Wen-Li Hwang, Chieh-Lin Jerry Ten. Circulating hematopoietic progenitors and CD34(+) cells predicted successful hematopoietic stem cell harvest in myeloma and lymphoma patients: experiences from a single institution. Journal of blood medicine. vol 7. 2016-02-26. PMID:26917978. |
previous studies have shown that the numbers of both circulating hematopoietic progenitor cell (hpc) and cd34(+) cell are positively correlated with cd34(+) cell harvest yield. |
2016-02-26 |
2023-08-13 |
Not clear |
| Paul J Simmons, Simon N Robinson, Mark F Munsell, Michael W Thomas, Jeannie A Javni, Nathalie Brouard, Patrick A Zweidler-McKay, Elizabeth J Shpal. Expression of a surface antigen (MA6) by peripheral blood CD34+ cells is correlated with improved platelet engraftment and may explain delayed platelet engraftment following cord blood transplantation. Stem cells and development. vol 24. issue 9. 2016-01-05. PMID:25674667. |
commitment of cd34(+)ma6(+) cells to the mk lineage was confirmed by in vitro assays and their significance in hematopoietic transplantation explored by flow cytometric analysis of cryopreserved samples of granulocyte colony stimulating factor-mobilized peripheral blood progenitor cell (pbpc) products along with a retrospective analysis of platelet engraftment data. |
2016-01-05 |
2023-08-13 |
Not clear |